title: Drugs, Inflammation, and the Eye.
authors.affiliation: a California Pacific Medical Center , San Francisco , California , USA .|b The Department of Ophthalmology , Stanford University School of Medicine , Stanford , California , USA .|c The Francis I. Proctor Foundation, UCSF School of Medicine , San Francisco , California , USA .|d West Coast Retina Medical Group , San Francisco , California , USA .
authors.forename: Emmett T
authors.initials: ET
authors.lastname: Cunningham
authors.affiliation: e Retina Consultants San Diego , La Jolla , California , USA .
authors.forename: Nikolas J S
authors.initials: NJ
authors.lastname: London
authors.affiliation: f Associated Vitreoretinal and Uveitis Consultants, Indiana University School of Medicine , Indianapolis , Indiana , USA .
authors.forename: Ramana
authors.initials: R
authors.lastname: Moorthy
authors.affiliation: g MidAtlantic Retina, The Retina Service of Wills Eye Hospital , Philadelphia , Pennsylvania , USA , and.
authors.forename: Sunir J
authors.initials: SJ
authors.lastname: Garg
authors.affiliation: h Centre for Ophthalmology, University Tuebingen , Tuebingen , Germany.
authors.forename: Manfred
authors.initials: M
authors.lastname: Zierhut
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000068438:Brimonidine Tartrate / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D000074324:Ipilimumab; D054517:Orbital Cellulitis / Q000139:chemically induced*; D004364:Pharmaceutical Preparations; D014606:Uveitis, Anterior / Q000139:chemically induced*
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000911:Antibodies, Monoclonal; D004164:Diphosphonates; D000074324:Ipilimumab; D004364:Pharmaceutical Preparations; D000068438:Brimonidine Tartrate